Skip to content

Diazyme DZ122A-CON

by Diazyme Laboratories, Inc.

Ref DZ122A-CON

Diazyme DZ122A-CON is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II) made by Diazyme Laboratories, Inc., registered in EUDAMED on 27 Oct 2026 (Basic UDI-DI B-DZ122A-CONL6), cleared under FDA 510(k) K060619 on 21 Jul 2006 and listed in FDA GUDID since 3 Nov 2016 (UDI-DI D-DZ122A-CONL6), active as of 7 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 7 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K060619

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-DZ122A-CONL6 Basic UDI-DI D-DZ122A-CONL6UDI-DIDate27 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID NumberD-DZ122A-CONL6 UDI-DI Date3 Nov 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK060619 Date21 Jul 2006DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-DZ122A-CONL6 registered 27 Oct 2026 Active
  • FDA 510(k) K060619 decided 21 Jul 2006 Active
  • FDA GUDID UDI-DI D-DZ122A-CONL6 listed 3 Nov 2016 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K060619
  2. Listed FDA GUDID D-DZ122A-CONL6
  3. Registered EUDAMED B-DZ122A-CONL6

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Diazyme Carbon Dioxide Enzymatic Control Set EUDAMED
Diazyme GUDID
Generic name
Carbon dioxide (CO2) IVD, control
Model / reference
DZ122A-CON
Primary DI / UDI-DI
D-DZ122A-CONL6 EUDAMED
00817089020054 GUDID
Basic UDI-DI
B-DZ122A-CONL6
510(k) Number
FDA product code
KHS, JJX
EMDN code
W0101050204 Electrolyte controls
GMDN term
Carbon dioxide (CO2) IVD, control
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
862.1160, 862.1660
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Primary DI / UDI-DIEUDAMED
D-DZ122A-CONL6
GUDID
00817089020054
Device classEUDAMED
Class IVD General
GUDID
Class II

The registries describe this device under different primary UDI-DIs (EUDAMED lists D-DZ122A-CONL6; FDA GUDID lists 00817089020054), so their flags are not compared. Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under ELECTROLYTE CONTROLS.

Other devices from Diazyme Laboratories, Inc.

See all devices from Diazyme Laboratories, Inc. →

Properties

  • Professional testing
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (21, all answered No)